Skip to main content

Table 1 Information fundamental for the inclusion of exposure and outcome data in GWAS

From: Influence of immune cells and inflammatory factors on Alzheimer’s disease axis: evidence from mediation Mendelian randomization study

Phenotype

Number of SNP

Cases

Controls

Sample size

Population

PMID

Alzheimer’s Disease

10,528,610

21,982

41,944

63,926

European

30,820,047

Inflammatory Factor

9,784,803

NA

NA

7118

European

27,989,323

Immune cell characteristics

14,304,991

NA

NA

1858

European

− 32,929,287